In January 2025, Labman announced its largest project to date: the design, construction, and support of an innovative drug discovery platform for a leading global pharmaceutical company. This ...
Labman was growing rapidly and sought to increase the creation of their own intellectual property, rather than working directly for industry. This would provide additional avenues for income growth by ...
The AI-optimized BALANCE (Bioreactor Automation for Learning and Adaptive Networked Control of Experiments) platform combines the skills of CPI (UK), Basetwo (Canada), Nicoya (Canada), and Labman ...
KITCHENER, Ontario & United Kingdom, July 24, 2025--(BUSINESS WIRE)--An international initiative will transform biologics and drug manufacturing through AI-driven multiplatform integration. The ...
23 rd March 2023, LONDON – Labman Automation, a UK-based company creating laboratory automation solutions, has partnered with collaborative robots (cobots) manufacturer, Universal Robots, to develop ...
Hosted on MSN
Labman leads international project to develop AI-powered bioreactor platform for next-generation biologics
Labman is proud to be involved in a groundbreaking Canada-UK collaboration to revolutionize biopharmaceutical manufacturing using cutting-edge automation, AI, and real-time process control. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results